Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. | Novartis is paying ...
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...
SHENZHEN, China, Oct. 8, 2024 /PRNewswire/ -- BAIYU Holdings, Inc. (Nasdaq: BYU) (the "Company" or "BAIYU"), a leading B2B bulk commodity e-commerce platform and supply chain service provider ...
European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data ...
BAIYU Holdings, Inc. (Nasdaq: BYU) (the "Company" or "BAIYU"), a leading B2B bulk commodity e-commerce platform and supply ...
BAIYU Holdings shares touched a 52-week low as the stock returned to Nasdaq, over a month after the Securities and Exchange Commission temporarily suspended trading. However, shares could possibly ...
SHENZHEN, China - BAIYU Holdings, Inc. (NASDAQ: BYU), a prominent B2B e-commerce and supply chain service provider, has filed an appeal against the Nasdaq's decision to delist the company's ...
SHENZHEN, China - BAIYU Holdings, Inc. (NASDAQ: BYU), a prominent B2B e-commerce and supply chain service provider, has filed an appeal against the Nasdaq's decision to delist the company's securities ...
BAIYU Holdings shares touched a 52-week low as the stock returned to Nasdaq, over a month after the Securities and Exchange Commission temporarily suspended trading. However, shares could possibly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback